Advertisement

Pancreatic Disease in Sjögren’s Syndrome and IgG4-Related Disease

  • Arezou Khosroshahi
  • John H. Stone
  • Vikram Deshpande
Chapter

Abstract

The pancreas is a compound tubular-alveolar gland composed of an exocrine portion (serous acini) and an endocrine portion (islets of Langerhans). The islet cells make up only 1% of the total pancreatic mass.

Keywords

Chronic Pancreatitis Autoimmune Pancreatitis Pancreatic Exocrine Insufficiency Serum IgG4 Concentration Lymphoplasmacytic Infiltrate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg CG, Vissink A, et al. Health-related quality of life, employment and disability in patients with Sjogren’s syndrome. Rheumatology (Oxford). 2009;48(9):1077–82.CrossRefGoogle Scholar
  2. 2.
    Cardell BS, Gurling KJ. Observations on the pathology of Sjögren’s syndrome. J Pathol Bacteriol. 1964;68:137–46.CrossRefGoogle Scholar
  3. 3.
    Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjoegren’s syndrome. A clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore). 1965;44:187–231.CrossRefGoogle Scholar
  4. 4.
    Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas – an autonomous pancreatic disease? Am J Dig Dis. 1961;6:688–98.PubMedCrossRefGoogle Scholar
  5. 5.
    Fenster F, Buchanan WW, Laster L, Bunim J. Studies of pancreatic function in Sjögren’s ­syndrome. Ann Intern Med. 1964;61:498–508.PubMedGoogle Scholar
  6. 6.
    Wakfram R, Kopelman H, Tsantoufas D, Williams Ft. Chronic pancreatitis, sclerosing cholangitis, and sicca complex in two siblings. Lancet. 1975;1:550–2.Google Scholar
  7. 7.
    Sjogren I, Wengle B, Korsgren M. Primary sclerosing cholangitis associated with fibrosis of the submandibular glands and the pancreas. Acta Med Scand. 1979;205(1–2):139–41.PubMedGoogle Scholar
  8. 8.
    Nieminen U, Koivisto T, Kahri A, Farkkila M. Sjogren’s syndrome with chronic pancreatitis, sclerosing cholangitis, and pulmonary infiltrations. Am J Gastroenterol. 1997;92(1):139–42.PubMedGoogle Scholar
  9. 9.
    Fukui T, Okazaki K, Yoshizawa H, Ohashi S, Tamaki H, Kawasaki K, et al. A case of autoimmune pancreatitis associated with sclerosing cholangitis, retroperitoneal fibrosis and Sjogren’s syndrome. Pancreatology. 2005;5(1):86–91.PubMedCrossRefGoogle Scholar
  10. 10.
    Pickartz T, Pickartz H, Lochs H, Ockenga J. Overlap syndrome of autoimmune pancreatitis and cholangitis associated with secondary Sjogren’s syndrome. Eur J Gastroenterol Hepatol. 2004;16(12):1295–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Eckstein RP, Hollings RM, Martin PA, Katelaris CH. Pancreatic pseudotumor arising in association with Sjogren’s syndrome. Pathology. 1995;27(3):284–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Nakamura M, Okumura N, Sakakibara A, Kawai H, Takeichi M, Kanzaki M. A case of Sjögren’s syndrome presenting pancreatitis symptoms which responded to steroid therapy. Proc Jpn Pancreas Soc. 1976;6:135–6.Google Scholar
  13. 13.
    Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40(7):1561–8.PubMedCrossRefGoogle Scholar
  14. 14.
    DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme and malabsorption in severe pancreatic insufficiency. N Engl J Med. 1973;288(16):813–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, et al. Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore). 2008;87(4):210–9.CrossRefGoogle Scholar
  16. 16.
    Sheikh SH, Shaw-Stiffel TA. The gastrointestinal manifestations of Sjogren’s syndrome. Am J Gastroenterol. 1995;90(1):9–14.PubMedGoogle Scholar
  17. 17.
    Ostuni PA, Gazzetto G, Chieco-Bianchi F, Riga B, Plebani M, Betterle C, et al. Pancreatic exocrine involvement in primary Sjogren’s syndrome. Scand J Rheumatol. 1996;25(1):47–51.PubMedCrossRefGoogle Scholar
  18. 18.
    Coll J, Navarro S, Tomas R, Elena M, Martinez E. Exocrine pancreatic function in Sjogren’s syndrome. Arch Intern Med. 1989;149(4):848–52.PubMedCrossRefGoogle Scholar
  19. 19.
    Nishimori I, Morita M, Kino J, Onodera M, Nakazawa Y, Okazaki K, et al. Pancreatic involvement in patients with Sjogren’s syndrome and primary biliary cirrhosis. Int J Pancreatol. 1995;17(1):47–54.PubMedGoogle Scholar
  20. 20.
    Hradsky M, Bartos V, Keller O. Pancreatic function in Sjogren’s syndrome. Gastroenterologia. 1967;108(5):252–60.PubMedCrossRefGoogle Scholar
  21. 21.
    Lankishc PG, Arglebe C, Chilla R. Pancreatic function in Sjogren’s syndrome. Dig Dis Sci. 1988;33:11.Google Scholar
  22. 22.
    Gobelet C, Gerster JC, Rappoport G, Hiroz CA, Maeder E. A controlled study of the exocrine pancreatic function in Sjogren’s syndrome and rheumatoid arthritis. Clin Rheumatol. 1983;2(2):139–43.PubMedCrossRefGoogle Scholar
  23. 23.
    Kelly CA, Katrak A, Griffiths ID. Pancreatic function in patients with primary Sjogren’s syndrome. Br J Rheumatol. 1993;32(2):169.PubMedCrossRefGoogle Scholar
  24. 24.
    Afzelius P, Fallentin EM, Larsen S, Moller S, Schiodt M. Pancreatic function and morphology in Sjogren’s syndrome. Scand J Gastroenterol. 2010;45(6):752–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Ramos-Casals M, Brito-Zeron P, Siso A, Vargas A, Ros E, Bove A, et al. High prevalence of serum metabolic alterations in primary Sjogren’s syndrome: influence on clinical and immunological expression. J Rheumatol. 2007;34(4):754–61.PubMedGoogle Scholar
  26. 26.
    Onodera M, Okazaki K, Morita M, Nishimori I, Yamamoto Y. Immune complex specific for the pancreatic duct antigen in patients with idiopathic chronic pancreatitis and Sjögren’s syndrome. Autoimmunity. 1994;19(1):23–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Sundkvist G, Lindahlg G, Koskinene P, Bolinder J. Pancreatic autoantibodies and pancreatic function in Sjögreńs syndrome. Int J Pancreatol. 1991;8:141–9.Google Scholar
  28. 28.
    Ludwig H, Schernthaner G, Scherak O, Kolarz G. Antibodies to pancreatic duct cells in Sjögren’s syndrome and rheumatoid arthritis. Gut. 1977;18:311–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Tsianos EB, Tzioufas AG, Kita MD, Tsolas O, Moutsopoulos HM. Serum isoamylases in patients with autoimmune rheumatic diseases. Clin Exp Rheumatol. 1984;2(3):235–8.PubMedGoogle Scholar
  30. 30.
    Szanto L, Farkas K, Gyulai E. On Sjogren’s disease. Rheumatism. 1957;13(3):60–3.PubMedGoogle Scholar
  31. 31.
    Bucher UG, Reid L. Sjogren’s syndrome: report of a fatal case with pulmonary and renal lesions. Br J Dis Chest. 1959;53:237–52.PubMedCrossRefGoogle Scholar
  32. 32.
    Kamisawa T, Tu Y, Egawa N, Tsuruta K, Okamoto A, Kodama M, et al. Can MRCP replace ERCP for the diagnosis of autoimmune pancreatitis? Abdom Imaging. 2009;34(3):381–4.PubMedCrossRefGoogle Scholar
  33. 33.
    Camatte R, Sarles H. Treatment of digestive disorders of allergic origin with prothipendyl hydrochloride (Dominal). Sem Hop. 1961;37:2989–94.PubMedGoogle Scholar
  34. 34.
    Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344(10):732–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Deshpande V, Chicano S, Finkelberg D, Selig MK, Mino-Kenudson M, Brugge WR, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006;30(12):1537–45.PubMedCrossRefGoogle Scholar
  36. 36.
    Deshpande V, Gupta R, Sainani NI, Sahani DV, Virk R, Ferrone CR, et al. Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance. Am J Surg Pathol. 2011;35:26–35.Google Scholar
  37. 37.
    Zhang L, Notohara K, Levy MJ, Chari ST, Smyrk TC. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007;20(1):23–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Sah RP, Chari ST, Pannala R, Sugumar A, Clain JE, Levy MJ, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010;139(1):140–8; quiz e12–3.PubMedCrossRefGoogle Scholar
  39. 39.
    Okazaki K, Kawa S, Kamisawa T, Shimosegawa T, Tanaka M. Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol. 2010;45(3):249–65.PubMedCrossRefGoogle Scholar
  40. 40.
    Frulloni L, Scattolini C, Falconi M, Zamboni G, Capelli P, Manfredi R, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol. 2009;104(9):2288–94.PubMedCrossRefGoogle Scholar
  41. 41.
    Sahani DV, Kalva SP, Farrell J, Maher MM, Saini S, Mueller PR, et al. Autoimmune pancreatitis: imaging features. Radiology. 2004;233(2):345–52.PubMedCrossRefGoogle Scholar
  42. 42.
    Irie H, Honda H, Baba S, Kuroiwa T, Yoshimitsu K, Tajima T, et al. Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol. 1998;170(5):1323–7.PubMedGoogle Scholar
  43. 43.
    Sugumar A, Levy MJ, Kamisawa T, JM Webster G, Kim MH, Enders F, et al. Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut. 2011;60(5):666–70.PubMedCrossRefGoogle Scholar
  44. 44.
    Sah RP, Chari ST. Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol. 2011;23(1):108–13.PubMedCrossRefGoogle Scholar
  45. 45.
    Ghazale A, Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102(8):1646–53.PubMedCrossRefGoogle Scholar
  46. 46.
    Raina A, Greer JB, Whitcomb DC. Serology in autoimmune pancreatitis. Minerva Gastroenterol Dietol. 2008;54(4):375–87.PubMedGoogle Scholar
  47. 47.
    Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med. 2006;355(25):2670–6.PubMedCrossRefGoogle Scholar
  48. 48.
    Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, Falconi M, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med. 2009;361(22):2135–42.PubMedCrossRefGoogle Scholar
  49. 49.
    Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41(7):626–31.PubMedCrossRefGoogle Scholar
  50. 50.
    Kasai T, Miyauchi K, Kurata T, Satoh H, Ohta H, Tanimoto K, et al. Long-term (11-year) statin therapy following percutaneous coronary intervention improves clinical outcome and is not associated with increased malignancy. Int J Cardiol. 2007;114(2):210–7.PubMedCrossRefGoogle Scholar
  51. 51.
    Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic’s HISORt criteria. J Gastroenterol. 2007;42 Suppl 18:39–41.PubMedCrossRefGoogle Scholar
  52. 52.
    Otsuki M, Chung JB, Okazaki K, Kim MH, Kamisawa T, Kawa S, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol. 2008;43(6):403–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol. 2003;98(12):2811–2.PubMedCrossRefGoogle Scholar
  54. 54.
    Deshpande V, Sainani NI, Chung RT, Pratt DS, Mentha G, Rubbia-Brandt L, et al. IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material. Mod Pathol. 2009;22(10):1287–95.PubMedCrossRefGoogle Scholar
  55. 55.
    Deshpande V, Mino-Kenudson M, Brugge W, Lauwers GY. Autoimmune pancreatitis: more than just a pancreatic disease? A contemporary review of its pathology. Arch Pathol Lab Med. 2005;129(9):1148–54.PubMedGoogle Scholar
  56. 56.
    Cheuk W, Chan JK. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol. 2010;17(5):303–32.PubMedCrossRefGoogle Scholar
  57. 57.
    Okazaki K, Uchida K, Miyoshi H, Ikeura T, Takaoka M, Nishio A. Recent concepts of autoimmune pancreatitis and IgG4-related disease. Clin Rev Allergy Immunol. 2011;41:126–38.Google Scholar
  58. 58.
    Geyer JT, Deshpande V. IgG4-associated sialadenitis. Curr Opin Rheumatol. 2011;23(1):95–101.PubMedCrossRefGoogle Scholar
  59. 59.
    Geyer JT, Ferry JA, Harris NL, Stone JH, Zukerberg LR, Lauwers GY, et al. Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010;34(2):202–10.PubMedCrossRefGoogle Scholar
  60. 60.
    Zen Y, Kitagawa S, Minato H, Kurumaya H, Katayanagi K, Masuda S, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol. 2005;36(7):710–7.PubMedCrossRefGoogle Scholar
  61. 61.
    Cornell LD, Chicano SL, Deshpande V, Collins AB, Selig MK, Lauwers GY, et al. Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol. 2007;31(10):1586–97.PubMedCrossRefGoogle Scholar
  62. 62.
    Lindstrom KM, Cousar JB, Lopes MB. IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria. Acta Neuropathol. 2010;120(6):765–76.PubMedCrossRefGoogle Scholar
  63. 63.
    Zen Y, Onodera M, Inoue D, Kitao A, Matsui O, Nohara T, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol. 2009;33(12):1833–9.PubMedCrossRefGoogle Scholar
  64. 64.
    Movitz C, Brive L, Hellstrand K, Rabiet MJ, Dahlgren C. The annexin I sequence gln(9)-ala(10)-trp(11)-phe(12) is a core structure for interaction with the formyl peptide receptor 1. J Biol Chem. 2010;285(19):14338–45.PubMedCrossRefGoogle Scholar
  65. 65.
    Bartholomew LG, Cain JC, Woolner LB, Utz DC, Ferris DO. Sclerosing cholangitis: its possible association with Riedel’s struma and fibrous retroperitonitis. Report of two cases. N Engl J Med. 1963;269:8–12.PubMedCrossRefGoogle Scholar
  66. 66.
    Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134(3):706–15.PubMedCrossRefGoogle Scholar
  67. 67.
    Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23(1):88–94.PubMedCrossRefGoogle Scholar
  68. 68.
    Khosroshahi A, Stone JR, Pratt DS, Deshpande V, Stone JH. Painless jaundice with serial multi-organ dysfunction. Lancet. 2009;373(9673):1494.PubMedCrossRefGoogle Scholar
  69. 69.
    Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34(12):1812–9.PubMedCrossRefGoogle Scholar
  70. 70.
    Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology. 2002;122(5):1264–9.PubMedCrossRefGoogle Scholar
  71. 71.
    Zen Y, Nakanuma Y. Pathogenesis of IgG4-related disease. Curr Opin Rheumatol. 2011;23(1):114–8.PubMedCrossRefGoogle Scholar
  72. 72.
    Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45(6):1538–46.PubMedCrossRefGoogle Scholar
  73. 73.
    Okazaki K, Uchida K, Ohana M, Nakase H, Uose S, Inai M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology. 2000;118(3):573–81.PubMedCrossRefGoogle Scholar
  74. 74.
    Aalberse RC, Schuurman J. IgG4 breaking the rules. Immunology. 2002;105(1):9–19.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  • Arezou Khosroshahi
    • 1
  • John H. Stone
    • 1
  • Vikram Deshpande
    • 2
  1. 1.Division of Rheumatology, Allergy and ImmunologyMassachusetts General HospitalBostonUSA
  2. 2.Department of PathologyMassachusetts General HospitalBostonUSA

Personalised recommendations